Delivery Order SPE2DB22D1106-SPE2DB25FFDM8
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, valued at $10,114.52. This firm fixed-price delivery order was competitively awarded without set-asides on August 4, 2025, with an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Herceptin 150 mg vials, a monoclonal antibody used in cancer treatment. This firm fixed-price delivery order, valued at $2,670.42, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 18, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.68 firm fixed-price contract is for the delivery of 4,567,615,883 units of Herceptin 150 mg vials. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Herceptin 150 mg vials. The contract has a firm fixed price of $21,937.68 and an ultimate completion date of January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 150 mg vials of the drug Herceptin, with a ceiling value of $26,704.20 and a performance period through July 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the procurement of HERCEPTIN 150 MG VIALS. The contract has a ceiling value of $26,704.20 and is a firm fixed price delivery order with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- The Defense Logistics Agency awarded a $10,146.62 firm fixed price delivery order to Amerisourcebergen Drug Corp for 150 mg vials of the cancer drug Herceptin. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 7, 2023 under the terms of the contract. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for worldwide logistics support. This delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $5,534.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg vials of the drug Herceptin. The order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, with performance taking place in Conshohocken, Pennsylvania through October 18, 2023. As a component of the U.S. Department of Defense, the Defense Logistics Agency supports America's armed...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,681.68, is for the delivery of HERCEPTIN 150 MG VIALS. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDM8Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,647.60 on August 14, 2025, for the supply of Herceptin 150 mg vials, with a completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle extending through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to meet competitive federal requirements through multiple contract vehicles with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.6k | 8/14/25 |